Key takeaways
- GHK is a tripeptide our bodies produce naturally, and its blood levels drop substantially with age, from roughly 200 ng/mL at age 20 to about 80 ng/mL by age 60.
- Review research suggests GHK-Cu can influence the expression of thousands of human genes tied to wound healing, anti-inflammatory pathways, and DNA repair.
- Much of the strongest evidence is from reviews, in vitro skin models, and mechanism studies rather than large human clinical trials.
- GHK-Cu is most studied in the context of skin remodeling and tissue regeneration, and is not an approved medical treatment for these uses in most jurisdictions.
- This article is educational only and not medical advice; any use should be evaluated and overseen by a licensed physician.
What is GHK-Cu?
GHK-Cu is a small copper-binding peptide. Its core, GHK, is a tripeptide made of three amino acids (glycine, histidine, and lysine) that occurs naturally in the human body and binds copper with high affinity to form the complex written as GHK-Cu.
One reason GHK has attracted research interest is that its levels appear to decline notably with age. According to a 2015 review in BioMed Research International, circulating GHK falls from roughly 200 ng/mL around age 20 to about 80 ng/mL by age 60. Because this decline coincides with reduced regenerative capacity in skin and other tissues, researchers have asked whether restoring GHK might support some of the body's repair processes. That question is still being explored rather than settled.
How it is thought to work
The most striking findings about GHK come from gene-expression research. A 2018 review in the International Journal of Molecular Sciences reported that GHK-Cu can modulate the activity of around 4,000 human genes, including those involved in wound healing, anti-inflammatory responses, and DNA repair. Rather than acting on a single target, GHK appears to nudge a broad network of pathways toward a more regenerative state.
In the skin specifically, GHK has been described as helping to balance collagen production and matrix metalloproteinase (MMP) activity, the enzymes that break down the skin's structural proteins. A 2020 review in Aging Pathobiology and Therapeutics also points to antioxidant and skin-remodeling properties. It is important to read these as proposed and observed mechanisms, not as guaranteed clinical outcomes.
What the research shows
The evidence base for GHK-Cu is a mix of review articles, laboratory work, and mechanism studies, and it is honest to say it leans more toward early and preclinical research than large human trials.
On the laboratory side, a 2023 study in the Journal of Cosmetic Dermatology examined GHK-Cu combined with hyaluronic acid in a skin model and found upregulation of collagen IV, a marker associated with skin regeneration. This is an in vitro finding, meaning it was observed in a controlled lab system rather than in living people. On the mechanistic side, a 2017 paper in Brain Sciences looked at GHK and gene expression patterns relevant to the nervous system and cognitive decline, again at the gene level rather than as a tested treatment.
Taken together, the research paints a consistent and interesting biological picture, but the strongest claims remain about mechanisms and models. GHK-Cu has not been validated in large, controlled human trials for the outcomes people often associate with it, and that gap matters when weighing what it may or may not do.
What it is being explored for, and who it may suit
The clearest research focus for GHK-Cu is skin: its role in collagen and MMP balance, antioxidant activity, and tissue remodeling. Broader interest in wound healing, anti-inflammatory effects, and DNA repair follows from the gene-modulation findings, and a smaller body of mechanism work has touched on the nervous system.
People who find GHK-Cu interesting are often those thinking about skin quality and the regenerative changes that come with aging. That said, GHK-Cu is best understood as an investigational and research-stage compound for most of these uses, and it is not an approved medical treatment for them in most jurisdictions. Whether it is appropriate for any individual is a clinical question, not a general one, and depends on a person's health context and goals.
How Strong Craft Regen approaches GHK-Cu
Strong Craft Regen is a coordination and education service, not a clinic. We help people understand the current evidence honestly, including where it is strong and where it is still early, and we coordinate care that is delivered by licensed physicians at Innovita Clinic in Vilnius, Lithuania.
That physician oversight is the point. Any decision about whether a compound like GHK-Cu is suitable, and in what form, belongs with a qualified doctor who can review your individual situation. Nothing in this article is medical advice or a recommendation to use GHK-Cu.
If you would like to understand your options and have your questions reviewed by a clinical team, you can book a call with us. We will walk you through what the research does and does not support, and coordinate the next steps under proper medical supervision.
The evidence
Selected peer-reviewed references, each verified against PubMed. Explore the full, filterable research library on our Science page.
This article is for educational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. GHK-Cu is discussed in the context of the published research; inclusion of a study does not imply a guaranteed outcome. Many of these compounds are investigational and not approved for the uses described in all jurisdictions. Any treatment decision should be made with a qualified physician. Individual results vary.